
Omaxe Q4 FY26 Results: Loss Rs 191 Cr, Revenue Rs 349 Crore
Updated: 18 May 2026 • 5:15 pm
Posted by:

Omaxe Q4 FY26 results were declared on May 15, 2026, at the board of directors meeting. Omaxe reported net loss of Rs 191 crore for the quarter ended March 31, 2026, down 28.2% YoY from Rs 149 crore in Q4 FY25, on revenue of Rs 349 crore. Omaxe is a real estate development company. Investors tracking Omaxe Q4 FY26 will find complete financial analysis, segment performance, and FY27 outlook in this article.
Click Here – Get Free Investment Predictions
Omaxe Q4 FY26 Financial Highlights
| Metric | Q4 FY26 | Comparison |
|---|---|---|
| Net Loss | Rs 191 crore | down 28.2% YoY from Rs 149 crore in Q4 FY25 |
| Revenue from Operations | Rs 349 crore | Q4 FY26 (quarter ended March 31, 2026) |
| Ticker | OMAXE | Sector: Real Estate |
Omaxe Q4 FY26 Performance Analysis
Omaxe Q4 FY26 results reflect the company’s operational performance during the January to March 2026 quarter. Omaxe operates in the real estate development space, a sector that faced headwinds during FY26 that impacted profitability; management guidance on the path to recovery in FY27 will be closely watched. The Q4 results cap the full FY26 year and set the baseline for FY27 guidance.
The reported loss reflects sector-specific challenges and cost pressures. Management’s FY27 plan for restoring profitability and growth will be the primary focus for investors tracking Omaxe Q4 FY26. Track Omaxe on the Univest Screener for live data and analyst ratings.
Key Business Factors for the company
Sectoral Demand and Revenue Momentum
Omaxe’s revenue of Rs 349 crore reflects the company’s ability to execute in a competitive real estate development environment. Q4 is typically the strongest quarter for most Indian companies as year-end government spending, project completions, and festival-driven demand peak. The revenue trajectory for FY27 will be determined by order book conversions, new contract wins, and demand visibility from key customers.
Margin and Profitability Outlook
The company PAT of Rs -191.0 crore reflects ongoing challenges that management expects to resolve through operational restructuring. A return to profitability in FY27 depends on demand recovery, cost rationalisation, and strategic investments in the core business.
FY27 Guidance and Business Outlook
Following the firm results, management commentary on FY27 revenue guidance, capital expenditure plans, dividend policy, and strategic priorities will be the key near-term catalysts for the stock. India’s robust GDP growth of 6.5%+ and the government’s sustained infrastructure and consumption push create a positive macro backdrop for FY27 across most sectors. Monitor Omaxe financials in real time on the Univest Screener.
Check the Univest Screener for live data
Download the Univest iOS App or Univest Android App to track live prices and SEBI-registered analyst research.
Frequently Asked Questions on Omaxe
What is the company’s PAT?
Ans. Omaxe reported a net loss of Rs 191 crore, down 28.2% YoY from Rs 149 crore in Q4 FY25. Results were declared on May 15, 2026. Full details are available from NSE/BSE regulatory filings. Verify all numbers before investing.
What is the company’s revenue?
Ans. The firm’s revenue from operations was Rs 349 crore for the quarter ended March 31, 2026. Track real-time financials on the Univest Screener.
When were Omaxe’s results announced?
Ans. The company results were announced on May 15, 2026, at the board of directors meeting approving audited financial statements for Q4 and the full year ended March 31, 2026.
What sector does Omaxe operate in?
Ans. Omaxe operates in the real estate development sector. Download the Univest iOS App or Univest Android App to track Omaxe and get SEBI-registered research.
Is Omaxe a good investment after Q4 FY26?
Ans. Investment decisions should be based on comprehensive analysis of fundamentals, sector dynamics, valuation, and individual risk appetite. This article does not constitute investment advice. Consult a SEBI-registered financial advisor before investing. This content is for educational purposes only.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Recent Posts
Patanjali Foods Analyst Review May 2026
Premier Energies Q4 FY26 Results: PAT Rs 457 Cr, Revenue Rs 2,230 Crore
Godawari Power and Ispat Analyst Review May 2026
Steel Authority of India Q4 FY26 Results: PAT Rs 1835 Cr, Revenue Rs 30,813 Crore
Transrail Lighting Analyst Review May 2026
Popular this week
Patanjali Foods Analyst Review May 2026
Premier Energies Q4 FY26 Results: PAT Rs 457 Cr, Revenue Rs 2,230 Crore
Godawari Power and Ispat Analyst Review May 2026
Steel Authority of India Q4 FY26 Results: PAT Rs 1835 Cr, Revenue Rs 30,813 Crore
Transrail Lighting Analyst Review May 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
